Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related mascular degeneration: two year results of the ANCHOR study
Publication
, Journal Article
Fekrat, S; Brown, DM; Michels, M; Kaiser, PK; Heier, JS; Sy, JP; Ianchulev, T; ANCHOR Study Group,
Published in: Ophthalmology
2009
Duke Scholars
Published In
Ophthalmology
Publication Date
2009
Volume
116
Start / End Page
57 / 65
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fekrat, S., Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., … ANCHOR Study Group, . (2009). Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related mascular degeneration: two year results of the ANCHOR study. Ophthalmology, 116, 57–65.
Fekrat, S., D. M. Brown, M. Michels, P. K. Kaiser, J. S. Heier, J. P. Sy, T. Ianchulev, and T. ANCHOR Study Group. “Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related mascular degeneration: two year results of the ANCHOR study.” Ophthalmology 116 (2009): 57–65.
Fekrat S, Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related mascular degeneration: two year results of the ANCHOR study. Ophthalmology. 2009;116:57–65.
Fekrat, S., et al. “Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related mascular degeneration: two year results of the ANCHOR study.” Ophthalmology, vol. 116, 2009, pp. 57–65.
Fekrat S, Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related mascular degeneration: two year results of the ANCHOR study. Ophthalmology. 2009;116:57–65.
Published In
Ophthalmology
Publication Date
2009
Volume
116
Start / End Page
57 / 65
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences